Pyoderma Gangrenosum After Enzymatic Debridement.
| Published in: | JGIM: Journal of General Internal Medicine Vol. 31; no. 5; pp. 585 - 586 |
|---|---|
| Main Authors: | , |
| Format: | case study Journal Article |
| Published: |
Springer Nature
May2016
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114603326&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 114603326 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08848734 4BF jtl: JGIM: Journal of General Internal Medicine issn: 08848734 maglogo: N pubinfo: dt: May2016 vid: 31 iid: 5 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 114603326 114603326 NLM26525384 114603326 10.1007/s11606-015-3532-y NLM26525384 PMC4835390 [Available on 05/01/17] 114603326 ppf: 585 ppct: 1 formats: tig: atl: Pyoderma Gangrenosum After Enzymatic Debridement. aug: au: Duncan, Mark Worswick, Scott affil: UCLA Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles USA sug: subj: Peptide Hydrolases Adverse Effects Pyoderma Gangrenosum Chemically Induced Dermatitis Medicamentosa Etiology Disease Progression Dermatitis Medicamentosa Pathology Pyoderma Gangrenosum Pathology Aged, 80 and Over Male Debridement Adverse Effects Peptide Hydrolases Therapeutic Use Debridement Methods Pyoderma Gangrenosum Therapy Scales Aged, 80 & over Male pubtype: Academic Journal doctype: case study Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|